🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

11/ The model and code are open-source 🔗. 🤖Code/Model: github.com/AIM-KannLab/Te… 📰Paper (free access link): ai.nejm.org/stoken/default… 🗞️Press release: massgeneralbrigham.org/en/about/newsr…

In a new study, researchers from Brigham and Women’s Radiation Oncology and colleagues used an #AI tool to help predict relapse of pediatric brain cancer. The study was published in NEJM. Read more: massgeneralbrigham.org/en/about/newsr… doi.org/10.1056/AIoa24… Benjamin Kann, MD

🧵1/ Big news in unresectable stage III NSCLC. The InTRist study is the first randomized trial comparing NAC vs. neoadjuvant chemoimmunotherapy (NAC-ICI) prior to definitive chemoradiotherapy (CRT). Early results are promising. Let’s dig in. 🔍 #LungCancer #RadOnc #ASCO25

It was a real honor working with Anant Madabhushi and C. Jillian Tsai, MD, PhD on this companion piece to our ASCO education session. Exciting things ahead for AI applied to #HNSCC clinical care

Here it is! KEYNOTE-689 primary publication online now NEJM. It’s been an incredible journey with DAdkins Siteman Cancer Center @WUSM. All started in early 2010s / now with U.S. FDA approval and a new standard of care! Dana-Farber News Brigham and Women's Hospital Brigham and Women’s Department of Surgery

Lean body mass–based oxaliplatin dosing reduces peripheral neuropathy in stage III colon cancer without compromising survival! ✅ Lower rates of grade ≥2 oxaliplatin-induced peripheral neuropathy ✅ Better quality of life ✅ No impact on relapse-free survival or overall survival

My lab’s 5-year NIH R01 grant, awarded to study gene therapy for hearing loss, was abruptly terminated. I want to share how this action has been incredibly harmful and disruptive, not just to my lab, but to the scientific process itself. 1/15

Are you driven to use AI to transform patient outcomes in oncology? My lab in the AI in Medicine Program (Mass General Brigham, Harvard Medical School) is seeking Postdoc Fellows to pioneer applications of AI—especially LLMs—in cancer care. More here: linkedin.com/posts/danielle…